Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Nuvectis Pharma Virtual KOL Event to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, including the Combination with Osimertinib in Non-Small Cell Lung Cancer

    Join Nuvectis Pharma for a virtual key opinion leader (KOL) event featuring Alexander Spira, MD, PhD, FACP, FASCO (Chief Scientific…
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details

    BrainsWay Virtual Analyst and Investor Day to Discuss the Company’s Growth Strategy and Deep Transcranial Magnetic Stimulation (Deep TMS™) for the Treatment of Mental Health and Addiction Conditions

    Join BrainsWay for a virtual Analyst and Investor Day during which company management will highlight various aspects of BrainsWay’s growth…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    • Transgene Webinar to Discuss New TG4050 Phase I Immunological Data Presented at SITC 2025 Supporting TG4050’s Potential Role in Preventing Relapse in HNSCC Patients

    Join Transgene for a virtual event to discuss new Phase I immunological data presented at SITC 2025 that support the…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Atea Pharmaceuticals Virtual HCV KOL Event

    Join Atea Pharmaceuticals for a virtual panel discussion featuring several hepatitis C (HCV) key opinion leaders (KOLs) including: Jordan Feld,…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    TriSalus Life Sciences Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids

    Join TriSalus Life Sciences for a virtual key opinion leader (KOL) event featuring Nicole Lamparello, MD (Weill Cornell Medicine, New…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Equillium Virtual KOL Event to Discuss EQ504: A Novel Aryl Hydrocarbon Receptor (AhR) Modulator for Ulcerative Colitis

    Join Equillium for a virtual key opinion leader (KOL) event where management will be joined by experts in their fields, Francisco…
    TIME: 12:00 PM EST
    LOCATION: Virtual
    View Details

    ProQR AX-0810 Virtual Investor and Analyst Event

    “Entering the Clinic with AX-0810: Establishing Safety, PK, and the Biomarker Roadmap for Proof of Target Engagement” Join ProQR Therapeutics…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    • Foghorn Therapeutics Virtual Investor Event to Review Pipeline Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs

    Join Foghorn Therapeutics for a virtual investor event to review key development updates for its Selective ARID1B degrader program which will…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    SELLAS Life Sciences Virtual R&D Day: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update

    Join SELLAS Life Sciences Group for a virtual R&D Day featuring key opinion leaders (KOLs), alongside company management, to discuss…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Innate Pharma In-Person and Virtual Lacutamab KOL Event: Clinical Perspectives & Market Outlook

    Join Innate Pharma for an in-person investor and analyst event to discuss lacutamab, a Phase 3 ready asset. The program…
    TIME: 8:00 AM EDT
    LOCATION: Park Terrace Hotel, 18 W 40th St, New York, NY 10018
    View Details

    Sensei Bio Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

    Join Sensei Biotherapeutics for a virtual key opinion leader (KOL) event featuring company leadership and Kyriakos Papadopoulos, MD (Co-Director of…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Corbus Pharmaceuticals In-Person and Virtual Investor Event to Discuss Dose Expansion Phase 1/2 Clinical Data for Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

    Join Corbus Pharmaceuticals for an in-person and virtual investor event featuring key opinion leaders (KOLs) Ari Rosenberg, MD (UChicago Medicine),…
    TIME: 10:00 AM CEST
    LOCATION: Berlin Marriott Hotel, Inge-Beisheim-Platz 1, 10785 Berlin, Germany and Live Webcast
    View Details

    Gain Therapeutics Parkinson’s Disease KOL Event: Biomarkers, Clinical Endpoints, and the Path to Disease Modification

    Please join Gain Therapeutics for a virtual key opinion leader (KOL) event discussing current thinking on biomarkers, clinical outcome scales,…
    TIME: 4:00 PM EDT
    LOCATION: Virtual
    View Details

    Apyx Medical Virtual KOL Event to Discuss the Commercial Launch of The AYON Body Contouring System

    Join Apyx Medical for a virtual key opinion leader (KOL) event featuring Paul Vanek, Jr., MD, FACS (Founder, President &…
    TIME: 12:00 PM EDT
    LOCATION: Virtual
    View Details

    Aclaris Therapeutics In-Person and Webcast R&D Day 2025: Addressing Gaps in Immuno-Inflammatory Markets

    Please join Aclaris Therapeutics for its R&D Day in Midtown, New York to discuss the Company’s progress in addressing therapeutic…
    TIME: 8:00 AM EDT
    LOCATION: Midtown, New York and Live Webcast
    View Details

    Ovid Therapeutics Webcast to Discuss OV329 Phase 1 Topline Results

    Details to follow.
    TIME: 8:30 AM EDT
    LOCATION: Virtual
    View Details